# CLCN4

## Overview
The CLCN4 gene encodes the chloride voltage-gated channel 4 (ClC-4), a transmembrane protein that functions as a chloride/proton ion exchanger. This protein is integral to maintaining cellular ion homeostasis, particularly within the endosomal membranes where it facilitates the exchange of chloride and hydrogen ions, crucial for endosomal acidification and receptor recycling processes (MohammadPanah2009An; Li2023Novel). ClC-4 is predominantly localized in the endoplasmic reticulum and can form homodimers or heterodimers with ClC-3, enhancing its functional capacity as a Cl^-/H^+ exchanger (Li2023Novel). The protein's structure includes multiple transmembrane domains and cytosolic cystathionine-beta-synthase (CBS) domains, which are essential for its ion channel function and regulation (Li2023Novel). Mutations in the CLCN4 gene have been linked to various neurological disorders, underscoring its significance in neuronal development and function (Jentsch2015Discovery).

## Structure
The CLCN4 gene encodes the ClC-4 protein, a chloride/proton ion exchanger consisting of 760 amino acids. The protein features several domains, including transmembrane (TM) domains and cytosolic cystathionine-beta-synthase (CBS) domains. The TM domains are crucial for ion channel function, while the CBS domains influence gating and localization, as well as regulate membrane components (Li2023Novel). ClC-4 is primarily found in the endoplasmic reticulum and can form homodimers or heterodimers with ClC-3, contributing to its function as a Cl-/H+ exchanger (Li2023Novel).

The protein's structure includes 12 predicted hydrophobic domains, which are integral to its function as a transporter (Li2023Novel). The gating glutamate residue is essential for coupling proton to chloride transport, and mutations in this residue can significantly alter the protein's function (Poroca2017ClC). ClC-4 can reach the plasma membrane when overexpressed, allowing for biophysical characterization, and exhibits strongly outwardly rectifying currents (Jentsch2018CLC).

Alternative isoforms of ClC-4 may exist due to alternative initiation sites, but some, like the human short isoform 2, are predicted to be nonfunctional due to the absence of essential parts, including the first transmembrane helix (Jentsch2018CLC).

## Function
The CLCN4 gene encodes the ClC-4 protein, a chloride/proton exchanger that plays a significant role in cellular ion homeostasis. ClC-4 is primarily localized to endosomal membranes, where it functions as a Cl^-/H^+ antiporter, facilitating the exchange of chloride and hydrogen ions. This activity is crucial for endosomal acidification, a process essential for the proper functioning of endosomal pathways, including the recycling of receptors like the transferrin receptor (MohammadPanah2009An).

In healthy human cells, ClC-4 contributes to the pH-dependent processing of the transferrin receptor, which is vital for iron uptake. The protein's role in endosomal acidification allows for the dissociation of iron from transferrin, enabling the recycling of the transferrin receptor to the cell surface and facilitating continued iron uptake (MohammadPanah2009An). ClC-4's function is specific to recycling receptors and does not extend to receptors targeted for degradation (MohammadPanah2009An).

ClC-4 is expressed in various tissues, including the brain, where it is implicated in neuronal development. Mutations in the CLCN4 gene have been associated with neurological disorders, highlighting its importance in brain function (Poroca2017ClC; Jentsch2015Discovery).

## Clinical Significance
Mutations in the CLCN4 gene are associated with a range of neurodevelopmental and neurological conditions. These include X-linked intellectual disability, epilepsy, and various behavioral disorders. The gene encodes the ClC-4 protein, a chloride/hydrogen ion exchanger, which plays a crucial role in the endo-lysosomal system. Disruptions in this system can lead to significant neurological symptoms (Palmer2016De; Guzman2022Functional).

Clinical features linked to CLCN4 mutations include intellectual disability, which can range from mild to profound, and epilepsy, with seizure onset often occurring within the first three years of life. Behavioral disorders such as ADHD, autism spectrum disorder, and anxiety are also prevalent. Neuroimaging frequently reveals white matter abnormalities, and some individuals exhibit agenesis of the corpus callosum (Palmer2016De; Palmer2022Functional).

The mutations can result in both gain-of-function and loss-of-function effects, each correlating with different phenotypic features. Gain-of-function variants are often associated with severe growth and gastrointestinal issues, particularly in females, while loss-of-function variants can lead to milder phenotypes (Palmer2022Functional). The complexity of CLCN4-related conditions necessitates comprehensive management, including psychiatric and neurogastroenterology care (Palmer2022Functional).

## Interactions
The CLCN4 gene encodes the ClC-4 protein, a chloride/proton ion exchanger that participates in several protein interactions crucial for its function. ClC-4 is known to form heterodimers with ClC-3, a closely related transporter, which is essential for its stability and function. This interaction is significant for maintaining ionic balance within vesicles, particularly in the nervous system, where it is implicated in neurological disorders (Palmer2022Functional). 

ClC-4 is primarily localized to the endoplasmic reticulum (ER) in excitable tissues such as the nervous system and skeletal muscle. Its N-terminal region is necessary for ER targeting, suggesting that interactions with other proteins or ancillary proteins might influence its localization in certain tissues (Okkenhaug2006The). ClC-4 has also been reported to colocalize with CFTR on the plasma membrane, with ClC-5 in endosomes, and with the copper pump ATP7B in the trans-Golgi network, indicating potential interactions with these proteins (Okkenhaug2006The). 

While ClC-4 may form heteromers with ClC-5, the physiological significance of this interaction remains unconfirmed (Stauber2012Cell). There is no specific information on ClC-4's interactions with nucleic acids.


## References


[1. (Palmer2016De) E E Palmer, T Stuhlmann, S Weinert, E Haan, H Van Esch, M Holvoet, J Boyle, M Leffler, M Raynaud, C Moraine, H van Bokhoven, T Kleefstra, K Kahrizi, H Najmabadi, H-H Ropers, M R Delgado, D Sirsi, S Golla, A Sommer, M P Pietryga, W K Chung, J Wynn, L Rohena, E Bernardo, D Hamlin, B M Faux, D K Grange, L Manwaring, J Tolmie, S Joss, J M Cobben, F A M Duijkers, J M Goehringer, T D Challman, F Hennig, U Fischer, A Grimme, V Suckow, L Musante, J Nicholl, M Shaw, S P Lodh, Z Niu, J A Rosenfeld, P Stankiewicz, T J Jentsch, J Gecz, M Field, and V M Kalscheuer. De novo and inherited mutations in the x-linked gene clcn4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females. Molecular Psychiatry, 23(2):222–230, August 2016. URL: http://dx.doi.org/10.1038/mp.2016.135, doi:10.1038/mp.2016.135. This article has 50 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/mp.2016.135)

[2. (Li2023Novel) Sinan Li, Wenxin Zhang, Piao Liang, Min Zhu, Bixia Zheng, Wei Zhou, Chunli Wang, and Xiaoke Zhao. Novel variants in the clcn4 gene associated with syndromic x-linked intellectual disability. Frontiers in Neurology, September 2023. URL: http://dx.doi.org/10.3389/fneur.2023.1096969, doi:10.3389/fneur.2023.1096969. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2023.1096969)

[3. (Okkenhaug2006The) Hanneke Okkenhaug, Karsten‐Henrich Weylandt, David Carmena, Dominic J. Wells, Christopher F. Higgins, Alessandro Sardini, Hanneke Okkenhaug, Karsten‐Henrich Weylandt, David Carmena, Dominic J. Wells, Christopher F. Higgins, and Alessandro Sardini. The human clc‐4 protein, a member of the clc chloride channel/transporter family, is localized to the endoplasmic reticulum by its n‐terminus. The FASEB Journal, 20(13):2390–2392, October 2006. URL: http://dx.doi.org/10.1096/fj.05-5588fje, doi:10.1096/fj.05-5588fje. This article has 28 citations.](https://doi.org/10.1096/fj.05-5588fje)

[4. (Jentsch2018CLC) Thomas J. Jentsch and Michael Pusch. Clc chloride channels and transporters: structure, function, physiology, and disease. Physiological Reviews, 98(3):1493–1590, July 2018. URL: http://dx.doi.org/10.1152/physrev.00047.2017, doi:10.1152/physrev.00047.2017. This article has 308 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00047.2017)

[5. (Jentsch2015Discovery) Thomas J. Jentsch. Discovery of clc transport proteins: cloning, structure, function and pathophysiology. The Journal of Physiology, 593(18):4091–4109, August 2015. URL: http://dx.doi.org/10.1113/JP270043, doi:10.1113/jp270043. This article has 121 citations.](https://doi.org/10.1113/JP270043)

[6. (Guzman2022Functional) Raul E. Guzman, Juan Sierra-Marquez, Stefanie Bungert-Plümke, Arne Franzen, and Christoph Fahlke. Functional characterization of clcn4 variants associated with x-linked intellectual disability and epilepsy. Frontiers in Molecular Neuroscience, May 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.872407, doi:10.3389/fnmol.2022.872407. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.872407)

[7. (Palmer2022Functional) Elizabeth E. Palmer, Michael Pusch, Alessandra Picollo, Caitlin Forwood, Matthew H. Nguyen, Vanessa Suckow, Jessica Gibbons, Alva Hoff, Lisa Sigfrid, Andre Megarbane, Mathilde Nizon, Benjamin Cogné, Claire Beneteau, Fowzan S. Alkuraya, Aziza Chedrawi, Mais O. Hashem, Hannah Stamberger, Sarah Weckhuysen, Arnaud Vanlander, Berten Ceulemans, Sulekha Rajagopalan, Kenneth Nunn, Stéphanie Arpin, Martine Raynaud, Constance S. Motter, Catherine Ward-Melver, Katrien Janssens, Marije Meuwissen, Diane Beysen, Nicola Dikow, Mona Grimmel, Tobias B. Haack, Emma Clement, Amy McTague, David Hunt, Sharron Townshend, Michelle Ward, Linda J. Richards, Cas Simons, Gregory Costain, Lucie Dupuis, Roberto Mendoza-Londono, Tracy Dudding-Byth, Jackie Boyle, Carol Saunders, Emily Fleming, Salima El Chehadeh, Marie-Aude Spitz, Amelie Piton, Bénédicte Gerard, Marie-Thérèse Abi Warde, Gillian Rea, Caoimhe McKenna, Sofia Douzgou, Siddharth Banka, Cigdem Akman, Jennifer M. Bain, Tristan T. Sands, Golder N. Wilson, Erin J. Silvertooth, Lauren Miller, Damien Lederer, Rani Sachdev, Rebecca Macintosh, Olivier Monestier, Deniz Karadurmus, Felicity Collins, Melissa Carter, Luis Rohena, Marjolein H. Willemsen, Charlotte W. Ockeloen, Rolph Pfundt, Sanne D. Kroft, Michael Field, Francisco E. R. Laranjeira, Ana M. Fortuna, Ana R. Soares, Vincent Michaud, Sophie Naudion, Sailaja Golla, David D. Weaver, Lynne M. Bird, Jennifer Friedman, Virginia Clowes, Shelagh Joss, Laura Pölsler, Philippe M. Campeau, Maria Blazo, Emilia K. Bijlsma, Jill A. Rosenfeld, Christian Beetz, Zöe Powis, Kirsty McWalter, Tracy Brandt, Erin Torti, Mikaël Mathot, Shekeeb S. Mohammad, Ruth Armstrong, and Vera M. Kalscheuer. Functional and clinical studies reveal pathophysiological complexity of clcn4-related neurodevelopmental condition. Molecular Psychiatry, 28(2):668–697, November 2022. URL: http://dx.doi.org/10.1038/s41380-022-01852-9, doi:10.1038/s41380-022-01852-9. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-022-01852-9)

[8. (Poroca2017ClC) Diogo R. Poroca, Ryan M. Pelis, and Valérie M. Chappe. Clc channels and transporters: structure, physiological functions, and implications in human chloride channelopathies. Frontiers in Pharmacology, March 2017. URL: http://dx.doi.org/10.3389/fphar.2017.00151, doi:10.3389/fphar.2017.00151. This article has 87 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2017.00151)

[9. (Stauber2012Cell) Tobias Stauber, Stefanie Weinert, and Thomas J. Jentsch. Cell biology and physiology of clc chloride channels and transporters. July 2012. URL: http://dx.doi.org/10.1002/cphy.c110038, doi:10.1002/cphy.c110038. This article has 124 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cphy.c110038)

[10. (MohammadPanah2009An) Raha Mohammad-Panah, Leigh Wellhauser, Benjamin E. Steinberg, Yanchun Wang, Ling Jun Huan, Xiang-Dong Liu, and Christine E. Bear. An essential role for clc-4 in transferrin receptor function revealed in studies of fibroblasts derived from clcn4-null mice. Journal of Cell Science, 122(8):1229–1237, April 2009. URL: http://dx.doi.org/10.1242/jcs.037317, doi:10.1242/jcs.037317. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.037317)